Thomas Vandervort

Partner

Avego Healthcare Capital

Joined: 2015


Get Started
 

    and access,

  •     37K PE/M&A Contacts
  •     +
  •     3.8K PE Firms
  •     3.0K M&A Advisors
  •     133K Transactions
  •     142K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Mr. Vandervort’s background ranges from numerous positions in the pharmaceutical services industry including the 3PL DDN Pharmaceutical Logistics and the ultra-orphan drug specialty pharmacy Centric Health Resources to leadership roles in business development for West-Ward Pharmaceuticals and IGI Laboratories (now Teligent, Inc.). As a sales leader for DDN and Centric, Mr. Vandervort built a brand for each company as the service provider of choice, as seen in the rapid growth in new clients and profitability for both companies. Mr. Vandervort ran M&A for West-Ward and was part of the team that acquired Baxter’s multi-source injectable business as well as numerous products that expanded West-Ward’s R&D portfolio to include NDAs as well as paragraph IV challenges. With IGI laboratories, Mr. Vandervort led multiple M&A transactions, including deals with Valeant and Concordia as well as the acquisition of the Canadian generic injectable company, Alveda Pharma, Inc. Mr. Vandervort has a BA from Bethany College in Bethany, WV and an MA from Duquesne University in Pittsburgh, PA.

Education